Showing results (91-100 of 200) with videos related to

Sort By:
Pageof 20
World Journal of Clinical Cases|July 10, 2024
Exploring the potential mechanism of WuFuYin against hypertrophic scar using network pharmacology and molecular dockingShu-Yang Zhang, Song-Xue Guo, Lei-Lei Chen, et al.
Scientific Reports|November 23, 2017
Sublethal effects of imidacloprid on targeting muscle and ribosomal protein related genes in the honey bee Apis mellifera LYan-Yan Wu, Qi-Hua Luo, Chun-Sheng Hou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in miceHuafeng Wei, Suhui Wang, Dapeng Zhang, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2026
A Three-Arm, Tiered Comparability Strategy Bridging Post-Approval Process Changes for an Omalizumab Biosimilar (CMAB007)Chenguang Wang, Chaoxin Zhou, Sheng Hou, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 9, 2024
Development of a reliable cell-based reporter gene assay to measure the bioactivity of anti-HER2 therapeutic antibodiesXiang Zhao, Weizhu Qian, Sheng Hou, et al.
European Journal of Pharmacology|February 9, 2011
A humanized anti-osteopontin antibody protects from Concanavalin A induced-liver injury in miceKexing Fan, Bo Zhang, Haiou Yang, et al.
Biochemical and Biophysical Research Communications|April 17, 2010
Development and characterization of a novel anti-IgE monoclonal antibodyWeizhu Qian, Xunmin Zhang, Bohua Li, et al.
Drug Design, Development and Therapy|March 19, 2019
Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression systemQing An, Yingxin Zheng, Yirong Zhao, et al.
Pageof 20